Serum glycobiomarkers for chronic inflammatory demyelinating polyneuropathy
Low levels of sialylated N-glycans could potentially serve as a novel biomarker, reflecting pathophysiology and therapeutic resistance in typical CIDP.
Authors
- Masaya Hane (ORCID: https://orcid.org/0000-0001-6830-2900)
- Keita Hiraga (ORCID: https://orcid.org/0000-0002-0134-2956)
- Hisatoshi Hanamatsu (ORCID: https://orcid.org/0000-0002-8461-2164)
- Masahisa Katsuno (ORCID: https://orcid.org/0000-0001-9453-9311)
- Ikuko Yokota
- Haruki Koike (ORCID: https://orcid.org/0000-0002-4612-3183)
- Chihiro Sato (ORCID: https://orcid.org/0009-0002-0426-5674)
- Soma Furukawa (ORCID: https://orcid.org/0000-0002-7377-8265)
- Ken Kitajima (ORCID: https://orcid.org/0000-0002-8541-6798)
- Yuki Fukami (ORCID: https://orcid.org/0000-0003-1117-5925)
- Jun‐ichi Furukawa (ORCID: https://orcid.org/0000-0002-7284-2261)
- Yuki Satake
- Satoru Yagi
Institutions
- Saga University (JP)
- Hokkaido University (JP)
- Nagoya University (JP)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-12-25
- DOI
- https://doi.org/10.1111/ene.70023
- Citations
- 1
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Japan Society for the Promotion of Science